Pneumocystis pneumonia in children receiving chemotherapy

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 896-898

  Prasad, Pinki ^a   Nania, Joseph J ^a   Shankar, Sadhna M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Hematology   (United States)

Author keywords

Cancer; Chemotherapy; Children; Pneumocystis pneumonia

Indexed keywords

ANTINEOPLASTIC AGENT; ATOVAQUONE; COTRIMOXAZOLE; DAPSONE; PENTAMIDINE;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFUSIONS, INTRAVENOUS; MALE; NEOPLASMS; OPPORTUNISTIC INFECTIONS; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 40449083223     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21202     Document Type: Article

References (20)

1. Sepkowitz KA, Brown AE, Telzak EE, et al. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. Jama 1992;267:832-837.
2. Roblot F, Le Moal G, Godet C, et al. Pneumocystis carinii pneumonia in patients with hematologic malignancies: A descriptive study. J Infect 2003;47:19-27.
3. Wolff LJ. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics. Am J Pediatr Hematol Oncol 1984;6:267-276.
4. Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for pneumocystis carinii pneumonitis. N Engl J Med 1977;297:1419-1426.
5. Castagnola E, Zarri D, Caprino D, et al. Cotrimoxazole prophylaxis of pneumocystis carinii infection during the treatment of childhood acute lymphoblastic leukaemia - Beware non compliance in older children and adolescents. Support Care Cancer 2001;9: 552-553.
6. Bozzette SA, Finkelstein DM, Spector SA, et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med 1995;332:693-699.
7. Ena J, Amador C, Pasquau F, et al. Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for pneumocystis carinii pneumonia. Clin Infect Dis 1994;18:901-904.
8. Schroeder KE, Barton SE. The use of intravenous pentamidine as prophylaxis against pneumocystis carinii pneumonia in patients with HIV infection. Int J STD AIDS 1994;5:353-355.
9. Yeung KT, Chan M, Chan CK. The safety of i.v. pentamidine administered in an ambulatory setting. Chest 1996;110:136-140.
10. Russian DA, Levine SJ. Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci 2001;321:56-65.
11. Sepkowitz KA. Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin Respir Infect 1992;7:114-121.
12. Harris RE, McCallister JA, Allen SA, et al. Prevention of pneumocystis pneumonia. Use of continuous sulfamethoxazole-trimethroprim therapy. Am J Dis Child 1980;134:35-38.
13. Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for pneumocystis carinii pneumonitis. N Engl J Med 1987;316:1627-1632.
14. Warnock AC, Rimland D. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of pneumocystis carinii pneumonia. Pharmacotherapy 1996;16:1030-1038.
15. Hughes WT, Dankner WM, Yogev R, et al. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Clin Infect Dis 2005;40:136-145.
16. Gupta M, Stephenson K, Gauar S, et al. Intravenous pentamidine as an alternate for pneumocystis carinii pneumonia prophylaxis in children with HIV infection. Pediatr Pulmonol Suppl 1997;16:199-200.
17. Schuval SJ, Bonagura VR. Failure of pentamidine as prophylaxis for pneumocystis carinii pneumonia in HIV-infected children. Arch Pediatr Adolesc Med 1994;148:876-879.
18. Weintrub PS, Wara DW, Duliege AM. Failure of intravenous pentamidine prophylaxis for pneumocystis carinii pneumonia. J Pediatr 1993;122:163-164.
19. Milstone AM, Balakrishnan SL, Foster CB, et al. Failure of intravenous pentamidine prophylaxis to prevent pneumocystis pneumonia in a pediatric hematopoietic stem cell transplant (HSCT) patient. Pediatr Blood Cancer 2006;47:859-860.
20. Hughes WT, Killmar JT, Oz HS. Relative potency of 10 drugs with anti-pneumocystis carinii activity in an animal model. J Infect Dis 1994;170:906-911.